Israel's biotechnology industry is bottom heavy—big on ideas but, so far, not on accomplishments. It needs to get its investors and scientists to talk.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Watzman, H., Avitzour, S. Israel's great expectations. Nat Biotechnol 19, 518–520 (2001). https://doi.org/10.1038/89239
Issue Date:
DOI: https://doi.org/10.1038/89239